DEF: Addus HomeCare 2026 Annual Meeting Proxy Statement

Addus HomeCare Corporation has filed its definitive proxy statement for the 2026 Annual Meeting of Shareholders to be held on June 10, 2026.

Summary

• The 2026 Annual Meeting of Shareholders will be held virtually on June 10, 2026, at 10:00 a.m. Central Time.
• Shareholders will vote on the election of two Class II directors, the ratification of PricewaterhouseCoopers LLP as independent auditor for 2026, and an advisory vote on executive compensation.
• The record date for voting is April 23, 2026, with 18,664,776 shares of common stock outstanding.
• The company achieved 2025 Adjusted EBITDA of $181,849,000, which was 104% of the target goal.
• Executive compensation for 2025 included base salary, performance-based cash bonuses, and performance-based equity awards tied to Adjusted EBITDA targets.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a stable, routine governance filing reflecting consistent operational performance and standard executive compensation practices.

Positives

• Achieved 2025 Adjusted EBITDA of $181,849,000, exceeding the target goal of $174,548,000.
• Strong shareholder support for executive compensation at the 2025 annual meeting.
• Maintains a robust corporate governance structure with a majority of independent directors and independent board committees.
• Successful transition of leadership roles, including the appointment of Heather Dixon as President and Chief Operating Officer.

Negatives

• The CEO-to-median-employee pay ratio is 753:1, based on 2025 compensation figures.
• A Form 5 was filed late for executive Monica Raines regarding a 2025 stock sale.

Risks

• Dependence on government reimbursement programs (Medicare/Medicaid) for a significant portion of revenue.
• Potential for cybersecurity threats and the need for ongoing investment in security infrastructure.
• Risks associated with the integration of acquisitions and the ability to achieve projected synergies.
• Regulatory and legislative changes impacting the homecare and healthcare services industry.

Future Outlook

The company continues to focus on long-term growth through acquisitions and organic expansion, maintaining Adjusted EBITDA as the primary metric for performance-based compensation in 2026.

Management Comments

• The Board believes that a combined role of Chairman and CEO, counterbalanced by a strong independent Lead Director, is in the best interests of the company.
• The company remains committed to high ethical standards and ESG initiatives that support long-term value creation.

Industry Context

StockSavvy.ai notes that Addus HomeCare operates in a highly regulated sector where government reimbursement policy and labor availability are critical success factors, consistent with broader trends in the home-based healthcare industry.

Comparison to Industry Standards

• The company utilizes a peer group for compensation benchmarking that includes Amedisys, Inc., Chemed Corporation, and Select Medical Holdings Corporation.
• The governance structure, including the use of a Lead Director and independent committees, aligns with standard practices for mid-cap healthcare services companies.

Management Changes

Corporate Governance

Legal Proceedings

• None disclosed.

Related Party Transactions

• The company paid $443,557 to Metasource, LLC in 2025, a company owned by an affiliate of Eos Management, L.P., where director Mark First serves as a Managing Director.

Stakeholder Impact

• Shareholders are requested to vote on director elections and executive compensation.
• Employees benefit from the company's focus on job creation and professional development.

Next Steps

• Hold the 2026 Annual Meeting of Shareholders on June 10, 2026.
• File the voting results in a Form 8-K within four business days of the meeting.
• Continue to execute on the 2026 strategic plan and performance goals.

Key Dates

Recommendation

The filing is a standard annual proxy statement with no major surprises or material changes to strategy, suggesting a hold position for investors awaiting further operational updates.

Keywords

Addus HomeCare, Proxy Statement, Executive Compensation, Corporate Governance, Home Healthcare, Adjusted EBITDA, Annual Meeting